Board of Directors (2018 - 2020)
President: LIZHENG SHI
Lizheng Shi, PhD, MsPharm, has trained as a pharmacist (B.S. in pharmacy, M.S. in pharmacy) through Shanghai Medical University and Peking Union Medical College, respectively. He has also trained as an economist (M.A. in economics, PhD in pharmaceutical economics and policy) through the University of Southern California. He is the Regents Professor and Interim Chair in the Department of Health Policy and Management at School of Public Health and Tropical Medicine and Clinical Faculty in Department of Medicine (Section of Endocrinology) and Department of Psychiatry at Tulane University. He is the Director for Tulane’s Health Systems Analytics Research Center (HSARC). He is the co-PI for Collaborative Program in Health Technology Assessment, which is funded by China Medical Board (CMB). He holds visiting professorship with Fudan University Key Lab of Health Technology Assessment since 2010 and visiting professor with Peking University China Health Development and Research Center since 2011. He is an associate editor for Value in Health and a member of editorial board for Pharmacoeconomics, Diabetes Therapy, and Global Health Journal. He was the past President (2014-2015) of Chinese Economists Society (CES). He is the president 2020-2022 of China Health Policy and Management Society (CHPAMS). Dr. Shi’s current research interest includes primary care transformation such as health care quality, access, and evaluation. He is also interested in pharmacoeconomics, health technology assessment, pharmacoepidemilogy with a focus on safety issues in medication treatment and medical informatics to improve quality and safety of patient care. He has published more than 160 papers in peer-reviewed journals and served as principal investigators (PI) and co-PI for more than 40 research grants and contracts from NIH, AHRQ, PCORI, and other public and private funding sources.
PRESIDENT-ELECT: LIANG WANG
Liang Wang, MD, DrPH, MPH, FACE, is Director of Epidemiology and tenured Associate Professor of Public Health at Baylor University. Previously, he was tenured Associate Professor and Assistant Professor of Epidemiology at ETSU College of Public Health. He is elected Fellow of the American College of Epidemiology and Fellow of The Obesity Society. He has been a Visiting Scientist at Harvard T. H. Chan School of Public Health and a Visiting Scholar at UNC Chapel Hill Gillings School of Global Public Health. His research focuses on obesity, nutrition epidemiology, health education and promotion, etc. Dr. Wang has published over 100 peer-reviewed papers (e.g., International Journal of Epidemiology, The American Journal of Clinical Nutrition, Journal of the American College of Cardiology), book chapters (e.g., International Encyclopedia of Public Health). He has been a PI and Co-I on multiple grants (e.g., NIH, PCORI). Dr. Wang has been serving as President-Elect of China Health Policy and Management Society (CHPAMS), Associate Director of China-Tennessee Health Education Training Institute, Chair of Public Relations of North America Chinese Society for Nutrition (NACSN), Founding President of the International Chinese Nutrition Young Scholar Network (ICNYSN), Founding President of Institute of Health Education and Lifecourse Promotion (iHELP). He has been awarded NACSN Outstanding Leadership and Service Award in 2016, ETSU College of Public Health (COPH) Dean’s Special Recognition Award for University Leadership Faculty Senate in 2017, ETSU COPH Dean’s Special Recognition Award for Service on the Faculty Council in 2017, and ETSU COPH College Foundation Service Award in 2018. He was nominated by Dean for ETSU University Distinguished Faculty Award for Service in 2019.
Secretary: LEI SI
Lei Si, PhD is a Senior Research Fellow in Health Economics and Health Systems Research at The George Institute for Global Health. He is a Conjoint Senior Lecturer at UNSW Medicine and an Adjunct Senior Research Fellow at Menzies Institute for Medical Research. He is a current National Health and Medical Research Council (NHMRC) Early Career Fellow. He was the Vice Chairman of the Australian Chinese Association of Biomedical Science, Tasmania Branch (2013-2018) and the Secretary-General of the Chinese Professional Association of Tasmania (2016-2018). He was also a committee member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)–Australia Chapter (2018-2019). Dr. Si has been involved in conducting evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for the Australian Government. Dr. Si mainly undertakes research in health economic evaluations. In addition, he works on health equality, equity of healthcare financing in China and discrete choice experiment. He has published more than 50 articles in peer-reviewed journals and two book chapters. Dr. Si has received research funding from the National Natural Science Foundation of China, the NHMRC, China Medical Board and so on. Dr. Si is an Associate Editor of BMJ Global Health and BMC Musculoskeletal Disorders.
Treasurer: DONGLAN ZHANG
Donglan Zhang, Ph.D., is an Assistant Professor of Health Policy and Management at the University of Georgia. Professor Zhang previously worked as a prevention effectiveness fellow at the Centers for Disease Control and Prevention. Her research focuses on health insurance coverage and access to health care, telemedicine, health disparities, policy simulation and prevention of chronic diseases in the United States and China. Professor Zhang's research has been funded by NIH, USDA, and other local funding sources. She has published more than 60 peer-reviewed articles with some on top health policy and public health journals. She recently received an NIH R01 grant to study the rural-urban disparities in cardiovascular diseases and how local and state policies in the clinical and community systems help mitigate these disparities. Her study on telemedicine and stroke care was published in Health Affairs and presented at the national press club and received the China Health Policy and Management Society Rising Scholar Best Paper award of 2018. Her research on nutrition labeling and sodium intake, telemedicine, rural physician shortages, and rural-urban health disparities and policies has been featured in local and national media. Dr. Zhang received her Ph.D. in Health Policy and Management from UCLA in 2014.
Director of Academics: JING LI
Jing Li, PhD is an Assistant Professor of Health Policy and Economics in the Department of Healthcare Policy and Research at Weill Medical College of Cornell University. Dr. Li obtained her PhD in Health Policy and MA in Economics from University of California, Berkeley. She also holds an MA from Stanford University and a BA from Peking University. A major strand of Dr Li’s research examines the incentives and behaviors of healthcare providers, as well as their impact on healthcare resource allocation, with special focus on the impact among aging population. More generally, she is interested in applying innovative and advanced research methodology in informing relevant questions in healthcare research and policy. Dr. Li has received funding support as PI from sources including the U.S. Agency for Healthcare Research and Quality (AHRQ), Weill Cornell Medicine, Russell Sage Foundation, and Cornell Center for Social Sciences. Her publications have appeared in leading journals including Proceedings of the National Academy of Sciences, Journal of Health Economics, Demography and Medical Care Research and Review. Dr. Li was a recipient of CHPAMS 2018 Rising Scholar Best Paper Award.
DIRECTOR OF MEMBERSHIP: JINGHUA LI
Dr. Jinghua Li is an Associate Professor at Department of Health Policy and Management, School of Public Health, Sun Yat-sen University. Dr. Li received her PhD degree from the Chinese University of Hong Kong, Master’s degree (in Global Health Policy) from the University of Tokyo, and Bachelor’s degree (in Building Science and Economics) from Tsinghua University. Her research interests include behavioral health, epidemiological modeling, economic evaluation, focusing on HIV-related research. She has authored/co-authored 36 publications in international peer-reviewed journals. She is the principle investigator of National Natural Science Foundation of China, China Medical Board, and Sun Yet-sen University 100 Talents Scheme.
Director of Fund Raising: CHANG LIU
Chang Liu, PhD is a Regional Director for Singapore, Mainland China, And Hong Kong. Dr. Chang Liu is responsible for the health and aging innovation platforms and leads research and consulting work for ACCESS Health International in the Greater China and ASEAN region. Chang has a held teaching positions at Duke-NUS, the National University of Singapore Enterprise, and the Chinese University of Hong Kong. He has authored a number of publications, including the Singapore overview for the International Profiles of Health Care Systems published by The Commonwealth Fund and London School of Economics. Dr. Liu got his PhD degree of Health Services Research from Brown University, specialized in health economics. He also received Master degree of finance from Guanghua School of Management, Peking University.
Director of Public Relations: HUIWEN XU
Huiwen Xu, Ph.D. is a Research Assistant Professor in the Department of Surgery, Cancer Control at University of Rochester Medical Center. He received his PhD in Health Services Research and Policy with Data Science training in 2019 from University of Rochester. Dr. Xu’s research focuses on long-term care, health policy, health disparities, and machine learning with large medical claims and advanced statistical methods. So far, Dr. Xu coauthored 35 peer-reviewed articles, including leading medical journals like JAMA Oncology, Medical Care, JAMDA, and JAGS; he also coauthored one book chapter and over 70 scientific abstracts. Dr. Xu has participated in 10 NCI/NIA/PCORI grants and received a Wilmot Cancer Institute Geriatric Oncology Pilot Grant recently. He is a SAS certified programmer with 3 certificates (Basic, Advanced, and Statistical Business Analyst) and cofounded the Rochester Data Science Society in 2016. Dr. Xu currently serves on the Executive Committee of AcademyHealth Methods and Data Council, Board of Directors of China Health Policy and Management Society (CHPAMS), and Analytics Core of Cancer and Aging Group. He is an Associate Editor of BMC Health Services Research and also serves as an ad hoc reviewer for 15 scientific journals. Dr. Xu received several awards, including the Best Oral Presentation from CHPAMS, Best Poster Award from Denver Post-Acute Care Conference, and Student Volunteer Award from AcademyHealth LTSS Interest Group etc.
PRESIDENTIAL COMMITTEE CHAIR (NON-VOTING MEMBER)
Mengxi Zhang, Ph.D., MPH, is an Assistant Professor in Health Science at Ball State University. She graduated from Tulane University with her Ph.D. in International Health and Development and Master Degree in Epidemiology. Prior to Tulane, she majored in Preventive Medicine in Capital Medical University. Her research focuses mainly on health promotion among refugees in the United States and immigrants in Southeast Asia. She is also interested in maternal and child health in minority groups. She has received various awards recognizing her work, including the Best Dissertation Award from Tulane University and Mekong Region Scholars Award from the University of Utah.
Link to Board of Directors (2016-2018)
Link to Board of Directors (2014-2016)